Brittany Young
Family · Lapeer, MINPI 1083251326
Payments from drug & device makers
Across 246 payments — averaging $27.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$952
- Novartis$910
- Johnson & Johnson$382
- Amgen$270
- Amarin Pharma, Inc.$225
- plus $2K from 25 others
What the payments were for
- Travel & lodging$1,18317%
- Food & beverage$5,60983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $2,276 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 53 | $952 |
| Novartis | 45 | $910 |
| Johnson & Johnson(2 entities) | 20 | $382 |
| Amgen | 20 | $270 |
| Amarin Pharma, Inc. | 13 | $225 |
| AbbVie | 5 | $204 |
| E.r. Squibb & Sons, L.L.C. | 11 | $187 |
| Merck | 9 | $164 |
| Kestra Medical Technology Services, Inc. | 5 | $152 |
| Intra-sana Laboratories | 1 | $124 |
| Pfizer | 7 | $116 |
| Abiomed | 1 | $115 |
| Boehringer Ingelheim | 5 | $106 |
| Actelion Pharmaceuticals US, Inc. | 6 | $101 |
| AstraZeneca | 6 | $100 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $70 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $51 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Angiodynamics, Inc. | 1 | $28 |
| Philips North America LLC | 2 | $28 |
| Cordis US CORP. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Cardiva Medical, Inc. | 1 | $20 |
| Edwards Lifesciences | 1 | $20 |
| Cvrx, Inc. | 1 | $19 |
| Biotronik Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$130
- Reltone 200 Mg$124
- GLYCATE$124
- Reltone 400 Mg$124
- QULIPTA$124
- UBRELVY$124
How this compares
$6,793 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 327 | $394,204 |
| EntrestoSacubitril/Valsartan | 52 | $76,479 |
| XareltoRivaroxaban | 45 | $48,715 |
| BrilintaTicagrelor | 52 | $45,498 |
| Praluent PenAlirocumab | 11 | $9,383 |
| Metoprolol Succinate | 245 | $4,809 |
| Atorvastatin Calcium | 190 | $2,872 |
| Losartan Potassium | 186 | $2,685 |
| Carvedilol | 164 | $2,432 |
| ClopidogrelClopidogrel Bisulfate | 106 | $2,364 |
| Nifedipine ErNifedipine | 61 | $2,061 |
| Metoprolol Tartrate | 219 | $1,640 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 77 | $1,608 |
| Ezetimibe | 51 | $1,152 |
| Midodrine Hcl | 17 | $1,008 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $116 | $394,204327 claims |
| NovartisEntresto | $910 | $76,47952 claims |
| Johnson & JohnsonXarelto | $382 | $48,71545 claims |
| AstraZenecaBrilinta | $100 | $45,49852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Lapeer
- David KocendaLapeer$49K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.